USE OF NEBIVOLOL AS AN ANTI-ATHEROGENIC

This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous...

Full description

Saved in:
Bibliographic Details
Main Authors DE CHAFFOY DE COURCELLES, DIDIER ROBERT GUY GABRIEL, LESAGE, ANNE SIMONE JOSEPHINE, LEYSEN, JOSEPHA EDUARDA MARIA FRANCISCA
Format Patent
LanguageEnglish
French
Published 17.10.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stres s.
Bibliography:Application Number: CA19952207333